Organization
Pfizer Inc, New York, United States
5 abstracts
Abstract
AN EXPLORATORY RESPONDER ANALYSIS IN THE SUBGROUP OF PATIENTS WITH CONNECTIVE-TISSUE–ASSOCIATED PULMONARY ARTERIAL HYPERTENSION (PAH) FROM THE SUPER-1 STUDY OF SILDENAFIL IN PAH Org: University of Colorado at Denver, Colorado, Pfizer Inc, New York, United States,
Abstract
A SAFETY ANALYSIS OF TOFACITINIB 5 MG TWICE DAILY ADMINISTERED AS MONOTHERAPY OR IN COMBINATION WITH BACKGROUND CONVENTIONAL SYNTHETIC DMARDS IN A PHASE 3 RHEUMATOID ARTHRITIS POPULATION Org: Altoona Center for Clinical Research, Duncansville, United States, Institut de Rhumatologie de Montréal, Montréal, Canada, Sarasota Arthritis Research Center, Sarasota, Pfizer Inc, Collegeville, Pfizer Inc, Groton,
Abstract
A RANDOMIZED CONTROLLED STUDY OF PREGABALIN IN PATIENTS WITH FIBROMYALGIA AND COMORBID DEPRESSION TAKING CONCURRENT ANTIDEPRESSANT MEDICATION Org: Pfizer Inc, Groton, Pfizer Inc, New York, United States,
Abstract
ASSESSMENT OF IMMUNOGENICITY OF LIVE ZOSTER VACCINATION IN RHEUMATOID ARTHRITIS PATIENTS ON BACKGROUND METHOTREXATE BEFORE AND AFTER INITIATING TOFACITINIB OR PLACEBO Org: Oregon Health and Sciences University, Portland, Pfizer Inc, New York, United States, CREATE Center, Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom, Geisel School of Medicine at Dartmouth, Lebanon, United States,
Abstract
ANALYSIS OF NON-MELANOMA SKIN CANCER ACROSS THE TOFACITINIB RHEUMATOID ARTHRITIS CLINICAL PROGRAMME Org: University of Alabama, Birmingham, United States, Seoul National University, Seoul, Korea, Republic Of, Dermatology and Laser Center of Maui, Maui, United States, University of Paris-Sud, Paris, France, Pfizer Inc, Groton, CT, United States of America,